Therini Bio
PrivateLast Round
Series A
Extension
May 14, 2025
Total Funding Raised
$107.32M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Therini Bio is a biotechnology company developing fibrin-targeting immunotherapies to treat neuroinflammatory and retinal diseases driven by vascular dysfunction.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Therini Bio Comparables
Compare Therini Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| NeuroTherapia, Inc. | 76% | |
| Alector | 74% | |
| Cerevance | 74% |
Therini Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | May 14, 2025 | ||||
| Series A | Apr 27, 2023 | ||||
| Grant | Sep 1, 2021 | ||||
| Seed | May 10, 2021 | ||||
| Seed | Feb 24, 2020 |
Key People
Founding team and executive leadership
Therini Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Apollo Ventures | Series A Extension |
| Dolby Family Ventures | Series A Extension, Series A, Seed |
| SV Health Investors | Series A Extension, Series A, Seed |
| NIH RADx | Grant |
| Blue Goose Capital | Series A Extension |
| National MS Society | Seed |
| The Foundation For A Better World | Series A Extension, Series A, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 2, 2026
Grew 25% QoQ, from 12 to 15 employees.
- May 13, 2026
Monthly visitors grew 391% MoM, from 250 to 1.2K.
Therini Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Therini Bio's valuation, stock price, and market status.
Is Therini Bio a public or private company?
Therini Bio is a private company.
What is the current stock price of Therini Bio?
Therini Bio is a private company with no public stock price. No recent secondary market data is available.
How much is Therini Bio worth (valuation)?
Valuation information for Therini Bio is not publicly available.
Can I buy Therini Bio stock?
Therini Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Therini Bio's last funding round?
Therini Bio's most recent funding round was Series A Extension on May 14, 2025.
Who are the main investors in Therini Bio?
Key investors in Therini Bio include Dolby Family Ventures, SV Health Investors, Angelini Ventures, Sanofi Ventures, Alzheimer's Drug Discovery Foundation.
Will Therini Bio IPO soon?
No public IPO plans have been announced for Therini Bio.
How can I track Therini Bio secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Therini Bio's secondary market activity and sign up for updates.